TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $541 | +38.4% | 21 | -99.9% | 0.00% | -100.0% |
| Q1 2023 | $391 | +3158.3% | 26,037 | +2410.8% | 0.00% | – |
| Q4 2022 | $12 | -98.8% | 1,037 | +207.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 337 | +6.6% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 316 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -50.0% | 316 | -0.3% | 0.00% | – |
| Q4 2021 | $6,000 | -92.1% | 317 | -86.2% | 0.00% | – |
| Q3 2021 | $76,000 | -15.6% | 2,300 | -1.9% | 0.00% | -100.0% |
| Q2 2021 | $90,000 | -18.2% | 2,345 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | +64.2% | 2,300 | +76.9% | 0.00% | 0.0% |
| Q4 2020 | $67,000 | +157.7% | 1,300 | +30.0% | 0.00% | – |
| Q3 2020 | $26,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |